Asthmatx Overview

The singular focus of Asthmatx, Inc. is to help patients with asthma breathe easier. We are developing an interventional medical device, called the Alair System, for the bronchoscopic treatment of patients with severe asthma. We have commenced clinical studies to evaluate the safety and efficacy of this device in potentially reducing the frequency and severity of asthma attacks and asthma...More»

The singular focus of Asthmatx, Inc. is to help patients with asthma breathe easier. We are developing an interventional medical device, called the Alair System, for the bronchoscopic treatment of patients with severe asthma. We have commenced clinical studies to evaluate the safety and efficacy of this device in potentially reducing the frequency and severity of asthma attacks and asthma medications. Multiple clinical studies are underway to evaluate the safety and efficacy of this device in potentially improving the lives of patients with asthma. One of these studies, the Air2Trial is presently enrolling patients.«Less